Apr 11Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
Feb 7Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
Jan 8Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders